Regeneron quarterly profit nearly doubles on strong demand for eczema drug

Tiger Newspress2021-11-04

Regeneron Pharmaceuticals Inc's third-quarter profit nearly doubled on Thursday, helped by robust demand for its blockbuster drugs Dupixent to treat eczema and eye treatment Eylea.

The company's net profit rose to $1.63 billion, or $14.33 per share, in the quarter ended Sept. 30, from $842.1 million, or $7.39 per share, a year earlier.

Its shares stayed flat in premarket trading.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Nebhol
2021-11-04
Nebhol
Like comment
- Lkl8:
  Yes
tinacheekyle
2021-11-04
tinacheekyle
Like
TVermeulen
2021-11-04
TVermeulen
Nice
- tinacheekyle:
  ok
munmunmia
2021-11-04
munmunmia
[Grin]
- zzcloud88zz:
  Commented

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1128009281?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-04 18:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128009281","market":"us","top_or_hot":-1,"title":"Regeneron quarterly profit nearly doubles on strong demand for eczema drug","media":"Tiger Newspress","content":"<p>Regeneron Pharmaceuticals Inc's&nbsp;third-quarter profit nearly doubled on Thursday, helped by robust demand for its blockbuster drugs Dupixent to treat eczema and eye treatment Eylea.</p>\n<p>The company's net profit rose to $1.63 billion, or $14.33 per share, in the quarter ended Sept. 30, from $842.1 million, or $7.39 per share, a year earlier.</p>\n<p>Its&nbsp;shares&nbsp;stayed&nbsp;flat&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/90064ebfa256d9f88d14a835c7409261\" tg-width=\"775\" tg-height=\"564\" width=\"100%\" height=\"auto\"></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron quarterly profit nearly doubles on strong demand for eczema drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron quarterly profit nearly doubles on strong demand for eczema drug\n</h2>\n\n<h4 class=\"meta\">\n\n2021-11-04 18:52 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regeneron Pharmaceuticals Inc's third-quarter profit nearly doubled on Thursday, helped by robust demand for its blockbuster drugs Dupixent to treat eczema and eye treatment Eylea.\nThe company's net ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":null,"article_id":"1128009281","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128009281","pubTimestamp":1636023159,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Regeneron Pharmaceuticals Inc's third-quarter profit nearly doubled on Thursday, helped by robust de","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"雷根龙季度利润几乎翻倍，因为湿疹药物需求强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":0.9},"content_text":"Regeneron Pharmaceuticals Inc's third-quarter profit nearly doubled on Thursday, helped by robust demand for its blockbuster drugs Dupixent to treat eczema and eye treatment Eylea.\nThe company's net profit rose to $1.63 billion, or $14.33 per share, in the quarter ended Sept. 30, from $842.1 million, or $7.39 per share, a year earlier.\nIts shares stayed flat in premarket trading.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":848734335,"gmtCreate":1636028394539,"gmtModify":1636028395193,"author":{"id":"3567411499210880","authorId":"3567411499210880","name":"Nebhol","avatar":"https://static.tigerbbs.com/b0bfc2a45b91e41a283614268857b3a5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like comment&nbsp;","listText":"Like comment&nbsp;","text":"Like comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848734335","repostId":1128009281,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6452908,"gmtCreate":1636029731724,"gmtModify":1636029731822,"authorId":3579588834516990,"author":{"id":3579588834516990,"authorId":3579588834516990,"name":"Lkl8","avatar":"https://static.tigerbbs.com/12361a2024c0ae8c8d97fd2339a79201","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848734335,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"CN"},{"id":848442983,"gmtCreate":1636023870065,"gmtModify":1636023870771,"author":{"id":"3575596393140561","authorId":"3575596393140561","name":"tinacheekyle","avatar":"https://static.tigerbbs.com/d2373874b2bf69f2637ce056a6f56ada","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848442983","repostId":1128009281,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":848446178,"gmtCreate":1636023788220,"gmtModify":1636023790720,"author":{"id":"3580699589385230","authorId":"3580699589385230","name":"TVermeulen","avatar":"https://static.tigerbbs.com/ffcbb09604bf679c78d4b172e4ad0c39","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848446178","repostId":1128009281,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6451928,"gmtCreate":1636023877920,"gmtModify":1636023877952,"authorId":3575596393140561,"author":{"id":3575596393140561,"authorId":3575596393140561,"name":"tinacheekyle","avatar":"https://static.tigerbbs.com/d2373874b2bf69f2637ce056a6f56ada","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848446178,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":848446945,"gmtCreate":1636023783785,"gmtModify":1636023783872,"author":{"id":"4095515414548690","authorId":"4095515414548690","name":"munmunmia","avatar":"https://static.tigerbbs.com/a11cb33621caef472d7766143198dd0a","vip":1,"crmLevel":8,"crmLevelSwitch":0},"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/848446945","repostId":1128009281,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6451962,"gmtCreate":1636024110405,"gmtModify":1636024110508,"authorId":3560223458534375,"author":{"id":3560223458534375,"authorId":3560223458534375,"name":"zzcloud88zz","avatar":"https://static.tigerbbs.com/c778f20822cc4b80c4c832a0775addbf","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":848446945,"type":1,"supId":0,"prevId":0,"content":"Commented","text":"Commented","html":"Commented"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":47,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128009281"}